<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis</title>
  <description>Dr. Aaron Zelikovich discusses&amp;amp;nbsp;how gefurulimab may offer an effective and convenient treatment option for adults with generalized myasthenia gravis. Show citation: Gwathmey KG, Saccà F, Howard JF Jr, et al. Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis: The PREVAIL Phase 3 Randomized Clinical Trial. JAMA Neurol. 2026;83(9):841-850. doi:10.1001/jamaneurol.2026.2333&amp;amp;nbsp; </description>
  <author_name>Neurology Minute</author_name>
  <author_url>https://www.aan.com/education-and-research/online-learning-programs/podcasts/neurology-minute-podcast</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/43604959/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/45403e/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/item/43604959</thumbnail_url>
</oembed>
